These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9589086)
1. Interferons in pediatric oncology: end of the beginning or beginning of the end? Kiss C Med Pediatr Oncol; 1998 Jun; 30(6):364-6. PubMed ID: 9589086 [No Abstract] [Full Text] [Related]
2. Interferons and cancer: the end of the beginning or the beginning of the end? Priestman TJ Clin Oncol; 1981 Dec; 7(4):271-4. PubMed ID: 6172229 [No Abstract] [Full Text] [Related]
5. Interferons and cancer: how the promise is being kept. Borden EC Interferon; 1983; 5():43-83. PubMed ID: 6202643 [No Abstract] [Full Text] [Related]
7. [Anti-tumor effects of interferon (author's transl)]. Sun Y Zhonghua Yi Xue Za Zhi; 1981 Sep; 61(9):556-8. PubMed ID: 6176299 [No Abstract] [Full Text] [Related]
8. Antitumor actions of interferons. Direct, indirect, and synergy with other treatment modalities. Tyring SK Int J Dermatol; 1987 Nov; 26(9):549-56. PubMed ID: 2450849 [No Abstract] [Full Text] [Related]
9. Antitumour actions of interferons: implications for cancer therapy. Parker BS; Rautela J; Hertzog PJ Nat Rev Cancer; 2016 Mar; 16(3):131-44. PubMed ID: 26911188 [TBL] [Abstract][Full Text] [Related]
10. Why do so many cancer patients fail to respond to interferon therapy? Einhorn S; Grander D J Interferon Cytokine Res; 1996 Apr; 16(4):275-81. PubMed ID: 9162520 [TBL] [Abstract][Full Text] [Related]
11. Interferon therapy. Williams CN Can J Gastroenterol; 1997 Oct; 11(7):563-4. PubMed ID: 9395755 [No Abstract] [Full Text] [Related]
12. [Antineoplastic effects of interferons]. Shimoyama M Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409 [No Abstract] [Full Text] [Related]
13. Interferon: a model for future biologicals. Oldham RK Interferon; 1985; 6():127-43. PubMed ID: 2410369 [No Abstract] [Full Text] [Related]
14. Combination of BRMs with chemotherapy. Tursz T Am J Med; 1995 Dec; 99(6A):56S-58S. PubMed ID: 8585538 [No Abstract] [Full Text] [Related]
15. Interferons in oncology: current status and future directions. Smyth JF; Balkwill FR; Cavalli F; Kimchi A; Mattson K; Niederle NE; Spiegel RJ Eur J Cancer Clin Oncol; 1987 Jun; 23(6):887-9. PubMed ID: 2443361 [TBL] [Abstract][Full Text] [Related]
16. [Interferons--a new treatment principle in oncology?]. von Wussow P; Hartmann F; Jakschies D Fortschr Med; 1988 Nov; 106(34):679-83. PubMed ID: 2463219 [No Abstract] [Full Text] [Related]
18. Interferon and malignant disease--how does it work and why doesn't it always? Grandér D; Einhorn S Acta Oncol; 1998; 37(4):331-8. PubMed ID: 9743454 [TBL] [Abstract][Full Text] [Related]
19. [Human interferons: biological and clinical promises and premises]. Jasmin C Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521 [TBL] [Abstract][Full Text] [Related]
20. [On the use and mechanisms of action of Interferon as antitumour substances (author's transl)]. Busse E; Rose H; Flöth L Radiobiol Radiother (Berl); 1980 Feb; 21(1):18-22. PubMed ID: 6162170 [No Abstract] [Full Text] [Related] [Next] [New Search]